Eyeworld

Archives EyeWorld.org EyeWorldTV.com EyeWorld ASCRS S AT U R DAY, M AY 16 , 2 0 2 0 | AS C R S V I R T U A L A N N U A L M E E T I N G DAILY NEWS HIGHLIGHTS ASCRS FOUNDATION UPDATE P. 6 FILM FESTIVAL PREVIEW P. 12 OPS WINNING IMAGES P. 28 way to help our members with the recovery process," he said. The meeting will feature more than 30 CME credits and more than 400 hours of content, and special sessions will highlight COVID-19-related content. Dr. Kim started by congrat- ulating and thanking Edward Holland, MD, chair of the ASCRS Program Committee, Steve Speares, ASCRS execu- tive director, ASCRS staff and leadership, industry sponsors, and participating faculty for by Ellen Stodola Editorial Co-Director T hough the ASCRS An- nual Meeting looks a bit different this year in its new, virtual for- mat, Terry Kim, MD, incoming president of ASCRS, said that it's a major step forward to ad- dress the current crisis, and he emphasized all the efforts that ASCRS is making to guide its members through these chal- lenging times. The Virtual Annual Meet- ing is an enormous initiative in terms of time and resources that ASCRS decided to under- take to address the COVID-19 crisis, Dr. Kim said. "We took this important step because we thought it would be the best their collaboration to make the very first Virtual Annual Meeting a reality. "We've never done a virtual meeting before, and due to having to cancel our Annual Meeting in Bos- ton fairly late, we didn't have much time to put this together. But thanks to the hard work and long hours put in by our Program Committee and ASCRS staff, we were able to produce a high-quality virtual Shifting gears to reflect on his year as president of ASCRS, Dr. Mamalis took a moment to pause and preface. "This terri- ble crisis in the whole country and what the entire profession is going through makes it diffi- cult to sit down and talk about what accomplishments have been done over the past year," Dr. Mamalis said. That said, he mentioned the rebranding of ASCRS that launched a year ago, making it clear what ASCRS does for its members and for surgeons. It's slogan—For surgeons. For you.—Dr. Mamalis said shows the commitment the society has for surgeons. "This is truly by Liz Hillman Editorial Co-Director N ick Mamalis, MD, outgoing president of ASCRS, shared his thoughts on the ASCRS Virtual Annual Meeting and his presidency as a whole. First, he gave "huge kudos" to the ASCRS staff and the Program Committee who took the full ASCRS Annual Meeting and distilled it into a 2-day virtual meeting in an extremely short period of time. "I'm very grateful that we were able to put togeth- er this meeting virtually," Dr. Mamalis said. "I am incredibly impressed at the amount of work everyone has been doing putting this together." Features he is excited for include the two-part "Turning the Lights Back On" session, which he said will be extremely timely for attendees. "The sessions on getting the practice going again, what are the steps to doing this … I think these are going to give invaluable information for people who are going through the process of restarting their practices," he said, adding later that these sessions come at a time when many states are be- ginning to loosen restrictions. He also noted the discus- sion with Scott Gottlieb, MD, former head of the FDA, who Dr. Mamalis said will likely offer valuable insights into this process. "The virtual meeting will also have the usual tremendous education that goes on at the ASCRS Annual Meeting," Dr. Mamalis said, mentioning that it even has a virtual exhibit hall for attendees to interact with industry representatives. continued on page 4 continued on page 3 Thoughts from outgoing ASCRS President Nick Mamalis, MD Incoming ASCRS President Terry Kim, MD, speaks about current situation and what ASCRS is doing to address this F R I DAY, J U LY 2 3 , 2 0 2 1 | A S C R S A N N UA L M E E T I N G DAILY NEWS EyeWorld: What was it like com- ing on as ASCRS president at the beginning of the pandemic? Dr. Kim: As I was taking on my role as president, I never imag- ined I'd face the immediate challenges that our organization had to face, but I was prepared to take on that challenge. I was thankful to have a strong and supportive organization in terms of the ASCRS staff, executive director, Executive Committee, and Governing Board to help nav- igate through the difficulties. For anyone dealing with this crisis, it was a dynamic, ever-evolving situ- ation; it was never just one thing. There were adjustments that were constantly being made in terms of our clinical care protocols, edu- cational offerings, governmental relief initiatives, and communica- tion with members. continued on page 4 continued on page 3 FOR MORE INFORMATION, VISIT US AT BOOTH #5201 SO YOUR PATIENTS DON'T HAVE TO © 2021 Ocular Therapeutix, Inc. All rights reserved. DEXTENZA is a registered trademark of Ocular Therapeutix, Inc. PP-US-DX-0323 OT_ASCRS_Daily_News_Banner_MECH_07Jul2021.indd 4 OT_ASCRS_Daily_News_Banner_MECH_07Jul2021.indd 4 7/14/21 11:28 AM 7/14/21 11:28 AM Visit Booth 5208 to Hear What's New at BVI BVI and all other trademarks (unless noted otherwise) are property of BVI. BVI ©2021 Outgoing ASCRS president reflects on unprecedented year A Q&A with ASCRS president Richard Hoffman, MD R ichard Hoffman, MD, the current ASCRS president, has been involved with ASCRS, EyeWorld, and the Journal of Cataract & Refractive Surgery for years. He shared his thoughts on his presidency and his vision for the society. T erry Kim, MD, served as ASCRS president during a year full of unprecedent- ed challenges brought on by the COVID-19 pan- demic. He reflected on his year as president, the challenges and how ASCRS addressed them, import- ant initiatives, and more. EyeWorld: How and when did you first become involved with ASCRS? Dr. Hoffman: I became involved with ASCRS in the mid-1990s, in part due to the work my part- ner, Howard Fine, MD, had been doing with ASCRS. Howard was teaching at meetings and in- volved in the Governing Board and Executive Committee and Daily News In 2019, ASCRS again conducted its Clinical Survey, which identifies education gaps by compiling data from respondents about their experiences across specialties. The survey in- cluded questions on cataract, refractive, cor- nea, glaucoma, and retina surgery. Information collected is used by ASCRS to guide educational initiatives and activities. The 2019 survey had 1,204 total ASCRS member respondents, with 54.9% practicing in the U.S. and 45.1% practicing elsewhere. Of the respondents, 73.3% were male and 26.7% were female. The survey respondents had a wide range of experience, from those cur- rently in residency or fellowship (11.2%) to those who have been in practice more than 30 years (17.3%). The largest percentage of respondents was those who have been in practice 21–30 years (25.3%), and 64.1% of respondents have been in practice for more than 10 years. Respondents also varied in where they perform surgery, with the largest percentage (32%) performing surgery in a surgeon-owned ASC. CLINICAL SURVEY 2019 HIGHLIGHTS OF THE 2019 ASCRS CLINICAL SURVEY HOW MANY YEARS HAVE YOU BEEN IN PRACTICE? WHERE IS YOUR PRIMARY SURGERY LOCATION? (Select all that apply.) WHERE PRACTICE IS LOCATED MALE VS. FEMALE RESPONDENTS SUPPLEMENT TO EYEWORLD JUNE 2022 Supported by CONNECTING THE DOTS: Advancements in cataract surgery NAVIGATING THE BUSINESS OF GLAUCOMA A n EyeWorld Cor- porate Education event at the 2024 American Acad- emy of Ophthal- mology (AAO) Annual Meet- ing featured presentations on "Navigating the Business of Glaucoma." The event was sponsored by AbbVie, Alcon, Bausch + Lomb, Glaukos, Nova Eye Medical, Sight Sciences, Théa, ViaLase, and Zeiss. Diagnostics and 'how doers get more done' In her presentation on diag- nostics, Lorraine Provencher, MD, first asked audience members, "What is your most valuable commodity?" She answered that for most, it's our time. "Constantly rushing to save time can feel like it's in direct opposition to the quality of care we provide," she said. Dr. Provencher noted that AAO recommends visual field testing once a year, but she said that some evidence indicates twice a year visual field testing may be the sweet spot. Unfortunately, more than 75% of patients with open angle glaucoma are getting less than one visual field a year. This is happening for a variety of reasons, including patient avoidance, clinic flow/staffing/space/time, and uncertainty with insurance/reimbursement. Dr. Provencher said that virtual reality perimetry has been a game changer for her practice to create efficiencies in visual field testing. "I have happier technicians with this; they love the improved workflow, and patients love it, too." There are better ergonomics for patients, she added. "It's often a faster test, and they're not moving around in the clinic." It also has a small footprint in the clinic, is often more affordable, and is more efficient. She called it a "slam dunk" for better care and better business. In terms of picking a virtual reality perimeter, she shared several considerations, including the battery life and weight, the validation population, background luminance, glaucoma staging accuracy, upfront vs. ongoing costs, soft- ware updates, warranty, and practice development tools. Her preference is the RadiusXR, which is a tablet-based headset. You can conveniently get an accurate visual field, interpret a familiar printout, and confidently make surgical decisions. There's a dashboard/portal to have open in the workroom to run multiple fields at once. What about OCT and optic nerve photos? Dr. Provencher likes data management systems. She noted the Zeiss Glaucoma Workplace, which integrates structure-func- tion from the CIRRUS, HFA, fundus images, and IOP. It also has at-a-glance summaries, you can add clinical events, and you can tailor it to add new baselines. It gives you a quick visual of what's been going on with the patient, she said. SLT: gateway to interventional glaucoma Manjool Shah, MD, discussed SLT. "The LiGHT Trial is the most [talked about] in my clinic on any given day," he said, adding that this showed that SLT works. 1 At 3 years, 74.2% of patients remained medication-free in the laser group; laser patients were more likely to be at IOP target at office visits (93% vs. 91.3%); disease progression was shown in 33 drop patients vs. 23 laser patients; glaucoma surgery (trabeculectomy) was required in 0 laser patients but 11 drop patients; and there was less visual field progression in the SLT group. You're capturing field progression across the spectrum, Dr. Shah said. DSLT lowers IOP in an efficient procedure that is comfortable for both patients and physicians. Improved procedure flow could help ophthalmology practices via word of mouth by increasing patient satisfaction and outcomes, Dr. Radcliffe said. Source: Nathan Radcliffe, MD Sahar Bedrood, MD, PhD Advanced Vision Care Los Angeles, California Lorraine Provencher, MD Vance Thompson Vision Omaha, Nebraska Nathan Radcliffe, MD New York Ophthalmology New York Eye Surgery Center New York, New York Manjool Shah, MD Kellogg Eye Center University of Michigan Ann Arbor, Michigan Inder Paul Singh, MD The Eye Centers of Racine and Kenosha Racine and Kenosha, Wisconsin About the physicians Supplements Growing your practice with new techniques and technologies FOR SURGEONS. FOR YOU. WWW.EYEWORLD.ORG JUNE 2022 VOLUME 27, NUMBER 2 2022 ASCRS ANNUAL MEETING RECAP P. 38 EVOLVING TREATMENTS AND TECHNIQUES IN OPHTHALMOLOGY IS GONIOSCOPY DEAD? CORNEAL CELL THERAPY A SHIFT TOWARD RLE WWW.EYEWORLD.ORG FOR SURGEONS. FOR YOU. WINTER 2024 VOLUME 29, NUMBER 4 ASCRS ASCRS News resources

• Cover